Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt Issuances
Ratios

Candel Therapeutics (CADL) Receivables - Net (2020 - 2021)

Candel Therapeutics' Receivables - Net history spans 2 years, with the latest figure at $1.1 million for Q4 2021.

  • For Q4 2021, Receivables - Net rose 72.44% year-over-year to $1.1 million; the TTM value through Dec 2021 reached $1.1 million, up 72.44%, while the annual FY2021 figure was $1.1 million, 72.44% up from the prior year.
  • Receivables - Net for Q4 2021 was $1.1 million at Candel Therapeutics, up from $191000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.1 million in Q4 2021 and bottomed at $191000.0 in Q1 2021.